Web Results

Acerus Pharmaceuticals Corporation - Home


Home · About Us · Our Company · Our Vision & Values · Leadership Team · Board of Directors · Technology · Products & Pipeline · ESTRACE® · NATESTO™  ...

Trimel BioPharma | LinkedIn


Trimel BioPharma Incorporated is now Trimel Pharmaceuticals Corporation. Trimel is a specialty pharmaceutical company actively developing medications for ...

Trimel Announces Closing of Exclusive Agreement for NATESTO(TM)


Dec 9, 2014 ... 9, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... agreement between its subsidiary, Trimel BioPharma SRL, and an affiliate of ...

Trivair Device: Home


Dose is delivered. The turbulent flow has completely emptied the device. Privacy Statement|; Terms of Use. © 2017 by Acerus Pharmaceuticals SRL.

Trimel Announces Exclusive License Agreement With Endo for ...


Nov 24, 2014 ... 24, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... Trimel Biopharma SRL, providing an affiliate of Endo International plc ...

Endo International unveils Natesto testosterone nasal gel | Mantality


Apr 23, 2015 ... Trimel BioPharma SRL announced the sale of acquisition rights to NATESTO<sup>TM</sup> testosterone nasal spray to Endo International plc in ...

Mattern Pharmaceuticals / The Nasal Company / News


The exclusive license rights MetP Pharma AG granted to Acerus associated with " Testosterone for women" have become in certain regions of the world ...

Endo Acquires Rights to Natesto™ Testosterone Nasal Gel


Nov 24, 2014 ... ... diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation (TSX: TRL).

NCT01446042 - ClinicalTrials.gov


Sep 30, 2011 ... Further study details as provided by Trimel Biopharma SRL: Primary Outcome Measures: Serum testosterone Cavg [ Time Frame: 90 days ] ...

Natesto - FDA


To report SUSPECTED ADVERSE REACTIONS, contact Trimel. BioPharma SRL at 1-844-Natesto (1-844-628-3786) or FDA at 1-800. FDA-1088 or ...